Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced movement disorders

O S Gershanik1

  • 1Seccion Enfermedades Extrapiramidales, Centro Neurologico-Hospital Frances, Buenos Aires, Argentina.

Current Opinion in Neurology and Neurosurgery
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Dendritic Spine Density and Inhibitory Perisomatic Connectivity onto Medium Spiny Neurons in L-Dopa-Induced Dyskinesia.

Molecular neurobiology·2019
Same author

Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.

Behavioural brain research·2004
Same author

Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice.

Brain research. Molecular brain research·2000
Same author

D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion.

Neuroreport·1999
Same author

The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies.

Advances in neurology·1999
Same author

Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions.

Neuroreport·1999
Same journal

Neuropharmacology.

Current opinion in neurology and neurosurgery·1993
Same journal

Disorders of the spinal cord and cauda equina.

Current opinion in neurology and neurosurgery·1993
Same journal

Autonomic disorders.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular and cell biology of addiction.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular mechanisms of trauma-induced neuronal degeneration.

Current opinion in neurology and neurosurgery·1993
Same journal

Excitatory amino acid receptors and epilepsy.

Current opinion in neurology and neurosurgery·1993
See all related articles

This review details movement disorders caused by antipsychotic drugs and other medications affecting dopamine in the brain. Recent studies have identified new syndromes and advanced understanding of their complex pathophysiology.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Antipsychotic drugs and other agents can cause movement disorders.
  • These disorders are linked to altered dopaminergic transmission in the basal ganglia.

Purpose of the Study:

  • To review major categories of drug-induced movement disorders.
  • To discuss recent advances in understanding their pathophysiology.

Main Methods:

  • Literature review of antipsychotic drug-induced movement disorders.
  • Analysis of recent studies on dopaminergic transmission and basal ganglia function.

Main Results:

  • New movement disorder syndromes secondary to pharmacologic agents have been reported.
  • Recent research has challenged or supported existing concepts regarding these disorders.

Related Experiment Videos

Conclusions:

  • Significant progress has been made in understanding the pathophysiology of drug-induced movement disorders.
  • Continued research is crucial for managing these complex neurological conditions.